Available since March 2026
Post-approval changes management (PAC) of vaccines faces manufacturers with a regulatory challenge due to the large quantities generated annually and the lack of harmonization in regulations and evaluation processes between NRAs (National Regulatory Authorities). Therefore, this may have an impact on patients' timely access to vaccines.
- Self-Paced
- EN